AC-73 and Syrosingopine Inhibit SARS-CoV-2 Entry into Megakaryocytes by Targeting CD147 and MCT4, 2024, Spinello et al.
Discussion in 'Long Covid research' started by SNT Gatchaman, Jan 23, 2024.
Discussion in 'Long Covid research' started by SNT Gatchaman, Jan 23, 2024.